11 August 2010
Welcome to the August edition of Pharmaceutical Insights. In this edition, we look at the public consultation the TGA is undertaking on changing the rules for the advertisement of therapeutic goods - what are the problems with the current system and what's being proposed?
We also look at changes to the regulation of prescription medicines in Australia, and why prudent manufacturers and importers should start thinking now about their potential exposure to liability from the use of nanotechnology.
By Alexandra Rose and Josephine Hayllar.